---
figid: PMC8073517__ijms-22-04185-g001
figtitle: 'Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid
  Hemorrhage Inflammation: A Systematic Review'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC8073517
filename: ijms-22-04185-g001.jpg
figlink: /pmc/articles/PMC8073517/figure/ijms-22-04185-f001/
number: F1
caption: Activation of toll-like receptor 4 (TLR4) via various damage-associated molecular
  pattern molecules (DAMPs) to initiate downstream signaling of the receptor after
  subarachnoid hemorrhage (SAH). Myleoid Diffrentiation 88 (MyD88) can be inhibited
  by the small molecular inhibitor, melatonin, fluoxetine and various flavonoids.
  TNF Receptor associated factor 6 (TRAF6) can be inhibited by the Resveratrol, whereas
  Desatanib targets the mitogen-activated protein kinase 3 (MAPK 3) pathway. TLR4
  pathway is associated with neuronal inflammation, apoptosis and activation of pro-inflammatory
  cytokines.
papertitle: 'Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid
  Hemorrhage Inflammation: A Systematic Review.'
reftext: Hammad Ahmed, et al. Int J Mol Sci. 2021 Apr;22(8):4185.
year: '2021'
doi: 10.3390/ijms22084185
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: stroke | pattern recognition receptors | aneurysms | neuro-inflammation
  | post-SAH complications
automl_pathway: 0.8891965
figid_alias: PMC8073517__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC8073517__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8073517__ijms-22-04185-g001.html
  '@type': Dataset
  description: Activation of toll-like receptor 4 (TLR4) via various damage-associated
    molecular pattern molecules (DAMPs) to initiate downstream signaling of the receptor
    after subarachnoid hemorrhage (SAH). Myleoid Diffrentiation 88 (MyD88) can be
    inhibited by the small molecular inhibitor, melatonin, fluoxetine and various
    flavonoids. TNF Receptor associated factor 6 (TRAF6) can be inhibited by the Resveratrol,
    whereas Desatanib targets the mitogen-activated protein kinase 3 (MAPK 3) pathway.
    TLR4 pathway is associated with neuronal inflammation, apoptosis and activation
    of pro-inflammatory cytokines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR3
  - TLR1
  - TLR2
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - FGA
  - FGB
  - FGG
  - MYD88
  - IRAK1
  - TRAF6
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF7
  - MAP3K7
  - NR2C2
  - CDK9
  - TIRAP
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TRIM69
  - TICAM1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - IRF3
  - Tlr3
  - Myd88
  - Irak1
  - Traf6
  - Nr2c2
  - Map3k7
  - Nfkbib
  - Tirap
  - Mdk
  - Ephb2
  - Mapk1
  - Tlr4
  - Nfkb1
  - Tmed7
  - Ticam2
  - Mapk3
  - Rnf138
  - Trim69
  - Ticam1
  - Mapk8
  - Jun
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Irf3
  - Ephb1
  - Rela
---
